Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00671086 · ClinicalTrials.gov registry record · Phase 3
Efficacy of Ramelteon in Subjects With Chronic Insomnia
A Phase 3 study of Sleep Initiation and Maintenance Disorders, sponsored by Takeda.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,213
- Enrollment target
- 20
- Study locations
NCT00671086 is a Phase 3 study of Sleep Initiation and Maintenance Disorders that has completed, run by Takeda. The registered enrollment target is 1,213 participants, above the 226-participant average among 19 other Sleep Initiation and Maintenance Disorders trials with a reported enrollment target (437% higher). The trial reports 20 study locations across 4 states.
The verdict
NCT00671086, a Phase 3 study of Sleep Initiation and Maintenance Disorders, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,213 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to determine the long-term safety of Ramelteon, once daily (QD), in subjects with chronic insomnia.
Conditions Studied
Interventions
- DRUG Ramelteon
Study Locations (20)
California
- - Anaheim
- - Burbank
- - Cerritos
- - Irvine
- - La Jolla
- - La Mesa
- - Lafayette
- - Murrieta
- - Newport Beach
- - Northridge
- - Redlands
- - Riverside
- - San Diego
- - San Francisco
Alabama
- - Birmingham
- - Mobile
Arizona
- - Phoenix
- - Tempe
Arkansas
- - Hot Springs
- - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,213 participants |
| Start Date | 2003-02 |
| Est. Completion | 2004-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00671086
The ClinicalTrials.gov registry entry for NCT00671086 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,213 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 226-participant average among 19 other Sleep Initiation and Maintenance Disorders trials with a reported enrollment target (437% higher). The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sleep Initiation and Maintenance Disorders appearing as the primary indexed condition, and to 1 intervention - of which Ramelteon is the first listed.
NCT00671086 reports 20 study locations spanning 4 distinct geographic areas - top geographies include California, Alabama, Arizona.
Frequently Asked Questions
What is clinical trial NCT00671086 about?
NCT00671086 is a clinical study titled "Efficacy of Ramelteon in Subjects With Chronic Insomnia". The purpose of this study is to determine the long-term safety of Ramelteon, once daily (QD), in subjects with chronic insomnia.
What is the current status of trial NCT00671086?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,213 participants. The study started on 2003-02. Estimated completion is 2004-09.
What conditions does trial NCT00671086 study?
This clinical trial studies the following conditions: Sleep Initiation and Maintenance Disorders.
What interventions are being tested in trial NCT00671086?
The interventions under investigation include: Ramelteon (DRUG).
Who is sponsoring clinical trial NCT00671086?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00671086 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Initiation and Maintenance Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus
COMPLETED · Phase 3
-
Mindfulness Meditation for Insomnia
RECRUITING · Phase 1
-
Optimizing Sleep Health in Nurses
RECRUITING · NA
-
Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
RECRUITING · Phase 2
-
Sleep for Health Study on the Effects of Cognitive Behavioral Therapy for Insomnia on Diabetes Risk
RECRUITING · NA
-
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.